levofloxacin has been researched along with glycidyl nitrate in 2 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (glycidyl nitrate) | Trials (glycidyl nitrate) | Recent Studies (post-2010) (glycidyl nitrate) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 7,749 | 8 | 3,379 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, M; Cheng, S; Gallardo, L; Hellman, J; Jackson, N; Konovalova, A; McNamara, C; Michel, LV; Pichichero, ME; Pierce, J; Snyder, E; Zavorin, M | 1 |
| Gui, Z; Li, J; Li, M; Li, X; Ma, H; Ma, Z; Sun, G; Tang, Q; Ye, X; Zhang, B | 1 |
2 other study(ies) available for levofloxacin and glycidyl nitrate
| Article | Year |
|---|---|
Ampicillin triggers the release of Pal in toxic vesicles from Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Escherichia coli; Escherichia coli Proteins; Gentamicins; Humans; Levofloxacin; Lipoproteins; Microbial Sensitivity Tests; Peptidoglycan; Sepsis | 2020 |
8-octyl berberine combats Staphylococcus aureus by preventing peptidoglycan synthesis.
Topics: Anti-Bacterial Agents; Berberine; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Docking Simulation; Peptidoglycan; Staphylococcal Infections; Staphylococcus aureus | 2023 |